Categories: All postsAnalysts

Tecsys gets upgraded to buy at Beacon Securities

Tecsys CEO Peter Brereton.
Supply chain management firm Tecsys (Tecsys Stock Quote, Chart TSX:TCS) is getting an upgrade from Beacon Securities analyst Gabriel Leung, who says that with its share price down 15 per cent year-to-date, its expanding healthcare footprint and the just-announced accretive acquisition of PCSYS A/S, the stock is now a “Buy” (previously “Hold”).

On Friday, Montreal-based Tecsys announced the acquisition of Danish technology company PCSYS A/S for $13.7 million in cash.

“PCSYS has found a like-minded customer-first spirit with Tecsys, and we are pleased to welcome their employees to our growing team,” said Peter Brereton, president and CEO of Tecsys, in a press release. “The PCSYS solutions are highly valued by many across the European market and beyond, and we’re pleased to be able to continue their tradition of collaborative software development and customer service as a unified force.”

Leung says the acquisition (PCSYS had revenue and operating profit of $15.4 million and $1.8 million, respectively, last fiscal year ended September 2018) adds to the rosier picture for TCS.

“While we will adjust our estimates for PCSYS post the release of the fiscal Q3 results (expected mid-March), we would argue that the acquisition does give us better comfort into our forward EBITDA forecasts,” the analyst said in a client update on Friday. “Based on our current FY20e (ending April 2020) EBITDA estimate of $10 million, the stock is trading at ~12.5x EV/EBITDA, which we view as an attractive entry point based on historical metrics.”

Leung adds that Tecsys continues to operate with a “very healthy” backlog of $51.7 million and that in its healthcare segment, the company is dealing with a $9.6-billion market opportunity of which Tecsys currently has about six per cent base account penetration and that with those base accounts, there is a $610-million opportunity of which the company has only penetrated 17 per cent.

“The point being, there’s still a lot of low hanging fruit that can drive Tecsys’ organic growth,” he says.

Leung’s “Buy” rating comes with an unchanged $15.00 target price which represents a projected return of 41 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: tcs
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Uber stock a buy? (May, 2024)

Following the release of the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on… [Read More]

2 days ago

Trulieve scores price target raise at Echelon

Following the company's most recent results, Echelon Capital Markets analyst Andrew Semple has raised his price target on Trulieve Cannabis… [Read More]

2 days ago

Is Green Thumb Industries a buy? (May, 2024)

Its first quarter numbers are in the books and Beacon Securities analyst Russell Stanley is still bullish on Green Thumb… [Read More]

3 days ago

Is TKO stock a buy?

Following the company's first quarter results, Roth MKM analyst Eric Handler has maintained his "Buy" rating on TKO Group (TKO… [Read More]

3 days ago

Is WELL Health stock a buy? (May, 2024)

Following the company's first quarter results, Eight Capital analyst Christian Sgro thinks there is a lot of money to be… [Read More]

3 days ago

“You Never Get Fired for Buying Shopify”

Its first quarter results are in the books and ATB Capital Markets analyst Martin Toner has become bullish on Shopify… [Read More]

3 days ago